西妥昔单抗
帕尼单抗
结直肠癌
医学
液体活检
肿瘤科
内科学
癌症
活检
作者
Caiming Xu,Alessandro Mannucci,F. Espósito,Helena Oliveres,Vicente Alonso Orduña,Alfonso Yubero,Carlos Fernández-Martos,Antonieta Salud,Javier Gállego,Marta Martı́n-Richard,Julen Fernández-Plana,M. Guillot Morales,Jorge Aparicio,Marwan Fakih,Scott Kopetz,Jaime Feliú,Joan Maurel,Ajay Goel
标识
DOI:10.1158/1078-0432.ccr-24-1934
摘要
The EXONERATE assay robustly predicted PFS and OS outcomes in patients with mCRC, both right- and left-sided, before they received either panitumumab or cetuximab. It stratified PFS, OS, and ORR better than a right versus left approach.
科研通智能强力驱动
Strongly Powered by AbleSci AI